Lanzado, Elljane P.
HRN: 18-61-62 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
CEFUROXIME 750MG (VIAL)
10/17/2023
10/23/2023
IV
365mg
Q8h
UTI
Waiting Final Action